Analytical Data
-
基因名
CG-3
- Application
-
别名
CG-3；ApolipoProtein L3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0DO16
-
表达区间
194-605aa
-
氨基酸序列
NPFLFGSNRFETLFKNQYGRIRVLQRFNQRSPQLQNLRDYRILEFNSKPNTLLLPNHADADYLIVILNGTAILSLVNNDDRDSYRLQSGDALRVPSGTTYYVVNPDNNENLRLITLAIPVNKPGRFESFFLSSTEAQQSYLQGFSRNILEASYDTKFEEINKVLFSREEGQQQGEQRLQESVIVEISKEQIRALSKRAKSSSRKTISSEDKPFNLRSRDPIYSNKLGKFFEITPEKNPQLRDLDIFLSIVDMNEGALLLPHFNSKAIVILVINEGDANIELVGLKEQQQEQQQEEQPLEVRKYRAELSEQDIFVIPAGYPVVVNATSNLNFFAIGINAENNQRNFLAGSQDNVISQIPSQVQELAFPGSAQAVEKLLKNQRESYFVDAQPKKKEEGNKGRKGPLSSILRAFY
-
分子量
54.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The CG-3 recombinant protein has garnered significant attention in the field of biotechnology and molecular biology due to its potential applications in therapeutics and diagnostics. Derived from the genome of a specific organism, CG-3 is involved in critical biological processes, including immune response modulation and cell signaling. Initial studies indicated that this protein exhibits unique structural and functional properties that could be harnessed for vaccine development, particularly in combating infectious diseases. Moreover, CG-3's interaction with various cellular pathways has led researchers to explore its role in cancer biology, where it may serve as a biomarker or therapeutic target. The recombinant production of CG-3 allows for large-scale synthesis, enabling detailed studies of its biochemical characteristics and biological activities. Furthermore, advancements in recombinant DNA technology have facilitated the engineering of CG-3 variants to enhance its efficacy and stability. As a result, the ongoing research focusing on CG-3 not only aims to elucidate its mechanisms of action but also seeks to translate these findings into practical applications that could improve public health outcomes. This research underscores the importance of understanding protein dynamics and interactions in developing innovative therapeutic strategies.
